Home|Journals|Articles by Year|Audio Abstracts
 

Original Research



Hemolytic and DNA nicking studies of anti-cancer peptide

Jagatheesh Kaliaperumal, Kowsalya Rangasamy, Parvathavarthini P,Pavankumar Padarthi, Elangovan Namasivayam.




Abstract

Background: In recent years studying of in vitro toxicity encompass their possess significance to proceed any compound to further pharmaceutical procedure. In this we taken peptide which is supposed to be bind with DNA to produce anti-cancer possessions so it requires studying for its genotoxic possessions.

Aims & Objective: To study Hemolytic and DNA nicking of anti-cancer peptide.

Materials and Methods: Simple agarose gel was used to electrophoresis to determine the DNA nicking property and hemolytic assay also performed to ensure the safety of the peptide in biological system.

Results: It was found that peptide is being safe even at elevated concentration 40 ng which cannot be achieved in biological distribution and the hemolytic assay shows the IC50 value 25.24 μg/ml which is also an awfully higher concentration in in vivo terms.

Conclusion: It is concluded the peptide have safe use in biological system.

Key words: Peptide; Electrophoresis; DNA Nicking; Haemolytic Assay






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.